ARRIVE - ABATACEPT RESEARCHED IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE ANTI-TNF RESPONSE TO VALIDATE EFFECTIVENESS Trademark

Trademark Overview

On Friday, March 27, 2009, a trademark application was filed for ARRIVE - ABATACEPT RESEARCHED IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE ANTI-TNF RESPONSE TO VALIDATE EFFECTIVENESS with the United States Patent and Trademark Office. The USPTO has given the ARRIVE - ABATACEPT RESEARCHED IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE ANTI-TNF RESPONSE TO VALIDATE EFFECTIVENESS trademark a serial number of 77700548. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, January 8, 2014. This trademark is owned by Bristol-Myers Squibb Company. The ARRIVE - ABATACEPT RESEARCHED IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE ANTI-TNF RESPONSE TO VALIDATE EFFECTIVENESS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use
arrive - abatacept researched in rheumatoid arthritis patients with an inadequate anti-tnf response to validate effectiveness

General Information

Serial Number77700548
Word MarkARRIVE - ABATACEPT RESEARCHED IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE ANTI-TNF RESPONSE TO VALIDATE EFFECTIVENESS
Filing DateFriday, March 27, 2009
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, January 8, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 12, 2010

Trademark Statements

Disclaimer with Predetermined Text"ABATACEPT RESEARCHED IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE.ANTI-TNF RESPONSE TO VALIDATE EFFECTIVENESS"
Goods and ServicesMedical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 31, 2009
Primary Code042
First Use Anywhere DateSunday, April 10, 2005
First Use In Commerce DateSunday, April 10, 2005

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Wednesday, January 8, 2014ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, January 8, 2014ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, May 24, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 24, 2013NON-FINAL ACTION E-MAILED
Friday, May 24, 2013SU - NON-FINAL ACTION - WRITTEN
Friday, May 3, 2013STATEMENT OF USE PROCESSING COMPLETE
Saturday, April 6, 2013USE AMENDMENT FILED
Monday, April 8, 2013TEAS STATEMENT OF USE RECEIVED
Tuesday, March 12, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 25, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, September 24, 2012EXTENSION 5 GRANTED
Friday, September 21, 2012EXTENSION 5 FILED
Friday, September 21, 2012TEAS EXTENSION RECEIVED
Saturday, March 24, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Friday, March 23, 2012EXTENSION 4 GRANTED
Wednesday, March 21, 2012EXTENSION 4 FILED
Wednesday, March 21, 2012TEAS EXTENSION RECEIVED
Thursday, September 15, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Wednesday, September 14, 2011EXTENSION 3 GRANTED
Monday, September 12, 2011EXTENSION 3 FILED
Monday, September 12, 2011TEAS EXTENSION RECEIVED
Tuesday, April 19, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 19, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 15, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, March 14, 2011EXTENSION 2 GRANTED
Thursday, March 3, 2011EXTENSION 2 FILED
Monday, March 14, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 3, 2011TEAS EXTENSION RECEIVED
Thursday, September 9, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, September 7, 2010EXTENSION 1 GRANTED
Tuesday, September 7, 2010EXTENSION 1 FILED
Tuesday, September 7, 2010TEAS EXTENSION RECEIVED
Tuesday, April 6, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 12, 2010PUBLISHED FOR OPPOSITION
Wednesday, December 23, 2009NOTICE OF PUBLICATION
Thursday, December 17, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 17, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 8, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, December 8, 2009ASSIGNED TO LIE
Thursday, November 19, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 9, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 9, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 9, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 22, 2009NON-FINAL ACTION MAILED
Friday, June 19, 2009NON-FINAL ACTION WRITTEN
Tuesday, June 16, 2009ASSIGNED TO EXAMINER
Tuesday, March 31, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, March 31, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

anti response validate effectiveness inadequate patients abatacept researched rheumatoid arthritis relating pharmaceutical preparations human trials clinical scientific research namely conducting